Switch to:
More From Other Websites
Immunomedics' Veltuzumab Receives Orphan Drug Status Nov 24 2014
AstraZeneca Targets More than $45B in Revenues in 2023 Nov 19 2014
Inovio-Roche End Deal for Development of Cancer Therapy Nov 18 2014
Celldex Therapeutics Surges on Positive Rindopepimut Data Nov 18 2014
Roche's (RHHBY) Avastin Label Expansion Approved by FDA Nov 18 2014
Puma Biotechnology Falls on Disappointing Neratinib Data Nov 17 2014
Celldex Immunotherapy Prolongs Survival for Recurrent Brain Tumor Patients Nov 14 2014
FDA Approves Genentech’s Avastin (bevacizumab) Plus Chemotherapy to Treat Women with... Nov 14 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

ReplySteve.dunfield@google - 7 months ago
Adjust for split?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial